[Clinical and experimental study of a new vasodilator; p-hydroxyphenyl-methyl-phenoxyethylamino propanol (CAA 40)].
D000433:1-Propanol; D001167:Arteritis / Q000628:therapy*; D000013:Congenital Abnormalities; D003327:Coronary Disease / Q000628:therapy*; D004423:Ear / Q000002:abnormalities; D004809:Ephedrine / Q000031:analogs & derivatives; D020005:Propanols; D014665:Vasodilator Agents
D020005:Propanols; D014665:Vasodilator Agents; D000433:1-Propanol; D004809:Ephedrine
ARTERITIS/therapy; CORONARY DISEASE/therapy; EPHEDRINE/related compounds
Contribution à l'étude clinique et expérimentale d'un vaso-dilatateur nouveau le p-hydroxyphényl méthyl phénoxyethylamino propanol (CAA 40).